During the past decade, GUZ Tula Regioanal Clinical Hospital; Hematology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "GUZ Tula Regioanal Clinical Hospital; Hematology" are "Idiopathic Thrombocytopenic Purpura" (2 trials) and "Lymphocytic Leukemia, Chronic" (2 trials). Many other conditions were trialed in "GUZ Tula Regioanal Clinical Hospital; Hematology" in a lesser frequency.

Most popular intervention types in "GUZ Tula Regioanal Clinical Hospital; Hematology" are "Biological" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (2 trials), "Fludarabine" (2 trials), "GNR-069" (2 trials), "Rituximab" (2 trials) and "Chlorambucil" (1 trials). Other intervention names were less common.

The vast majority of trials in "GUZ Tula Regioanal Clinical Hospital; Hematology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "GUZ Tula Regioanal Clinical Hospital; Hematology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in GUZ Tula Regioanal Clinical Hospital; Hematology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in GUZ Tula Regioanal Clinical Hospital; Hematology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".